<HashMap><database>biostudies-literature</database><scores><citationCount>0</citationCount><reanalysisCount>0</reanalysisCount><viewCount>45</viewCount><searchCount>0</searchCount></scores><additional><submitter>Leignadier J</submitter><funding>Swiss National Science Foundation</funding><pagination>e1086861</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4839323</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>5(3)</volume><pubmed_abstract>Cytotoxic T lymphocytes (CTL) from CD8?-deficient mice have powerful FasL-mediated cytotoxicity and IFN? responses, but ablated Ca&lt;sup>2+&lt;/sup> and NFAT signaling, which can be restored by transduction with CD8?. Upon infection with lymphocytic choriomeningitis virus (LCMV), these cells yielded GP33-specific CTL (CD8?R) that exhibited high FasL/Fas-mediated cytotoxicity, IFN? CXCL9 and 10 chemokine responses. Transfer of these cells in B16-GP33 tumor bearing mice resulted in (i) massive T cell tumor infiltration, (ii) strong reduction of myeloid-derived suppressor cells (MDSCs), regulatory T cells (Treg) and IL-17-expressing T helper cells, (iii) maturation of tumor-associated antigen-presenting cells and (iv) production of endogenous, B16 melanoma-specific CTL that eradicated the tumor long after the transferred CD8?R CTL perished. Our study demonstrates that the synergistic combination of strong Fas/FasL mediated cytotoxicity, IFN? and CXCL9 and 10 responses endows adoptively transferred CTL to reprogram the tumor environment and to thus enable the generation of endogenous, tumoricidal immunity.</pubmed_abstract><journal>Oncoimmunology</journal><pubmed_title>CD8 engineered cytotoxic T cells reprogram melanoma tumor environment.</pubmed_title><pmcid>PMC4839323</pmcid><funding_grant_id>310030</funding_grant_id><pubmed_authors>Luescher IF</pubmed_authors><pubmed_authors>Luther SA</pubmed_authors><pubmed_authors>Leignadier J</pubmed_authors><pubmed_authors>Favre S</pubmed_authors><view_count>45</view_count></additional><is_claimable>false</is_claimable><name>CD8 engineered cytotoxic T cells reprogram melanoma tumor environment.</name><description>Cytotoxic T lymphocytes (CTL) from CD8?-deficient mice have powerful FasL-mediated cytotoxicity and IFN? responses, but ablated Ca&lt;sup>2+&lt;/sup> and NFAT signaling, which can be restored by transduction with CD8?. Upon infection with lymphocytic choriomeningitis virus (LCMV), these cells yielded GP33-specific CTL (CD8?R) that exhibited high FasL/Fas-mediated cytotoxicity, IFN? CXCL9 and 10 chemokine responses. Transfer of these cells in B16-GP33 tumor bearing mice resulted in (i) massive T cell tumor infiltration, (ii) strong reduction of myeloid-derived suppressor cells (MDSCs), regulatory T cells (Treg) and IL-17-expressing T helper cells, (iii) maturation of tumor-associated antigen-presenting cells and (iv) production of endogenous, B16 melanoma-specific CTL that eradicated the tumor long after the transferred CD8?R CTL perished. Our study demonstrates that the synergistic combination of strong Fas/FasL mediated cytotoxicity, IFN? and CXCL9 and 10 responses endows adoptively transferred CTL to reprogram the tumor environment and to thus enable the generation of endogenous, tumoricidal immunity.</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Mar</publication><modification>2021-02-21T00:30:12Z</modification><creation>2019-03-27T02:12:06Z</creation></dates><accession>S-EPMC4839323</accession><cross_references><pubmed>27141342</pubmed><doi>10.1080/2162402x.2015.1086861</doi><doi>10.1080/2162402X.2015.1086861</doi></cross_references></HashMap>